
Canthera Discovery
Melbourne, Australia cantheradiscovery.com
From their website, Nov 2026
Work here? Claim this listing
About
Canthera Discovery is an oncology-focused small molecule drug discovery and development organisation in Melbourne, Australia. It works with research institutes, universities, biotechnology companies, and industry partners to move cancer research into preclinical and clinical development.
Services
Collaborative partnerships
Builds project teams with multiple institutes and disciplines to support drug discovery collaborations and data-driven decision-making.
e-Research Technologies
Provides data management, analysis, visualization tools, and an electronic laboratory notebook for standardized research data capture and sharing.
Translational cancer biology
Develops and validates target-specific functional bioassays, biomarker assays, in vivo models, and imaging strategies for evaluating novel compounds.
Drug metabolism and pharmacokinetics
Provides physicochemical profiling, permeability, metabolism, metabolite profiling, drug-drug interaction analysis, in vivo pharmacokinetics, stability testing, impurity profiling, preclinical formulation development, solid-state characterization, and salt sel
ADME, DMPK & toxicology
Structural biology
Determines protein structures and protein/inhibitor complexes using crystallography, in-house crystallization labs, the Australian Synchrotron, and X-ray facilities.
Recombinant protein production
Produces, purifies, and characterizes recombinant proteins from bacterial, insect, and mammalian cell lines for high-throughput screening and structural studies.
Protein production
Medicinal chemistry
Supports HTS triage, lead generation, and lead optimization to identify and optimize lead series toward clinical candidates.
High throughput screening
Develops and miniaturises molecular, cell-based, and high-content assays, runs HTS campaigns, and uses compound management and fragment screening capabilities.
Capabilities
- Processes
- Small molecule · Recombinant protein · Small molecules · HTS · PK/PD
- Capacity
- Two established HTS facilities in Australia · More than 100 HTS campaigns · More than 100 proteins produced successfully · More than 50 collaborative drug discovery programs · More than 15 novel candidates moved into clinical development
Equipment
- Australian Synchrotron
- Rigaku MicroMax 007HF
- RAXIS4++ area detector
- Electronic laboratory notebook (ELN)
Materials
- Insect cells
Industries served
- Biotechnology
- Pharmaceutical
Company
- Type
- CRDMO
- Founded
- 2007
Locations
- Address
- 305 Grattan Street Melbourne Victoria 3000
- Sites
- Melbourne, Australia
- Serves
- Australia
Contacts
- General enquiry
- enquiries@cantheradiscovery.com on their site
- Phone
- +61 3 9117 6730
Similar labs
Work here? Claim this listing